Company intelligence / Profile preview

Promedica International

Costa Mesa, California, United Statespromedica.org ↗

Ownership: Private
Development stage: Commercial

Overview

PMI has nearly forty years’ experience providing specialized clinical research services to medical device, biotech, and pharmaceutical companies globally. The company has an impressive track record supporting sponsor approvals across all phases of development with particular expertise in ophthalmology. In January 2024 it was acquired by iuvo BioScience to create a leading integrated provider for end-to-end laboratory and clinical development services focused on eye care.

Therapeutic areas: Ophthalmology
Modalities: Device (Medical devices)Biologic (Biologics for ophthalmology)Small molecule (Pharmaceuticals)
Industry: Contract Research Organization

Partnerships

Ampersand Capital PartnersNumerous partnerships with global sponsors in medical device/pharma/biotech sectors

Beyond the preview

Go deeper on Promedica International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Promedica International.

Explore the full profile